Global Newcastle Disease Vaccine Market was valued at US$ 300.97 million in 2022 and is projected to surpass a valuation of US$ 441.29 million by 2031 at a CAGR of 3.9% During the Forecast Period 2023–2031.
Newcastle disease (ND) is a highly contagious viral infection that affects poultry populations worldwide. It poses a significant threat to the poultry industry due to its high prevalence, mortality rate, and economic impact. The global Newcastle disease vaccine market has been witnessing growth due to increasing poultry production, rising demand for poultry products, and the need for effective disease management. The global prevalence of ND is estimated to range between 2% and 10%, with higher rates observed in specific regions. In India, for instance, the prevalence is estimated to be between 10% and 20%.
The mortality rate of ND varies depending on the strain of the virus. Velogenic ND, the most virulent strain, can result in mortality rates of up to 90%. This high mortality rate is a cause for concern, as it can lead to substantial losses in poultry populations and negatively impact the industry.
The economic impact of ND on the poultry industry is significant. In 2021, it was estimated that the global economic losses due to ND reached $1.4 billion. These losses are attributed to various factors, including mortality of infected birds, reduced productivity in surviving birds, costs associated with disease control and prevention measures, and trade restrictions imposed to prevent the spread of the disease.
To Get more Insights, Request A Free Sample
The global Newcastle disease vaccine market is experiencing steady growth. The increasing consumption of poultry products worldwide is creating a greater demand for disease prevention and control measures in the poultry industry. Governments are also playing a significant role by implementing strict regulations and guidelines that mandate vaccination programs and biosecurity measures to prevent the spread of ND.
Technological advancements, such as the development of advanced vaccines and diagnostic tools, are further contributing to market growth. These innovations offer improved efficacy and convenience in vaccine administration, attracting investments from market players. International trade and export opportunities are also influencing the market as outbreaks of ND can lead to trade restrictions and bans on poultry product exports. To maintain access to international markets, poultry producers and governments in the global Newcastle disease vaccine market prioritize disease prevention through vaccination. Growing awareness and education about the economic and health implications of ND are driving the adoption of vaccines as a preventive measure.
Regional variations in disease prevalence and government interventions contribute to variations in market dynamics across different regions. With a competitive landscape, market players are actively involved in research and development activities, strategic collaborations, mergers, and acquisitions to gain a competitive edge.
In recent years, there has been a notable trend towards increasing focus on vaccination programs and biosecurity measures in the global Newcastle disease (ND) vaccine market. With the aim of preventing and controlling outbreaks of ND, poultry producers, governments, and industry stakeholders are recognizing the importance of implementing robust vaccination programs and enhancing biosecurity practices.
Vaccination plays a vital role in reducing the spread and impact of Newcastle disease, and there is a growing awareness of its benefits. Poultry producers in the Newcastle disease vaccine market are increasingly incorporating vaccination protocols as a routine practice to safeguard their flocks and ensure the production of healthy birds. Governments, especially in poultry-dense regions, are promoting vaccination campaigns and providing support to farmers to implement comprehensive vaccination strategies.
Furthermore, biosecurity measures are being prioritized to prevent the introduction and spread of Newcastle disease. This includes implementing strict control measures for visitors, vehicles, and equipment, as well as practicing good hygiene and sanitation practices on farms. The combination of vaccination programs and biosecurity measures is becoming a crucial trend in the global Newcastle disease vaccine market to minimize disease outbreaks and protect poultry populations.
Newcastle disease virus (NDV) has a high mutation rate, leading to the formation of different strains with varying degrees of virulence. These new strains can pose challenges in terms of vaccine effectiveness and disease control. The virulent strains of NDV can evade the immunity provided by existing vaccines, leading to vaccine failures and outbreaks. As the virus evolves, it can develop antigenic variations that are not effectively targeted by current vaccines. This necessitates continuous surveillance and monitoring of circulating NDV strains to ensure that vaccines are updated and modified accordingly.
Developing and producing vaccines that effectively protect against a broad range of NDV strains is a complex task in the Newcastle disease vaccine market. It requires ongoing research and development efforts to identify conserved antigenic regions and incorporate them into vaccines. Additionally, ensuring widespread adoption and distribution of updated vaccines poses logistical challenges.
The emergence of new virulent strains underscores the need for constant vigilance, advanced diagnostics, and flexible vaccine development strategies to address the evolving nature of Newcastle disease. Overcoming this challenge is essential to maintain effective disease control and minimize economic losses in the poultry industry.
In terms of type, the global Newcastle disease vaccine market is dominated by killed vaccines. These vaccines are produced by inactivating the Newcastle disease virus, typically using chemical or physical methods, while retaining the ability to induce an immune response in vaccinated birds. Killed vaccines offer advantages such as ease of production, stability, and consistent immune response induction. In 2022, the killed vaccine segment accounted for a significant share, generating a revenue of $227.47 million.
The killed vaccine segment is projected to experience steady growth during the forecast period, with a compound annual growth rate (CAGR) of 4.3%. This growth can be attributed to the increasing adoption of killed vaccines in poultry farms worldwide. Poultry producers are recognizing the importance of disease prevention and are implementing vaccination programs using killed vaccines to protect their flocks from Newcastle disease outbreaks. Additionally, advancements in vaccine production technologies and research efforts to improve vaccine efficacy and safety are further driving the growth of the killed vaccine segment.
In terms of end users, the global Newcastle disease vaccine market is dominated by the chicken segment. Chickens are the primary beneficiaries of Newcastle disease vaccination due to their significant presence in the poultry industry. In 2022, the chicken segment accounted for a substantial revenue of $256.22 million.
The chicken segment is projected to maintain its dominance and exhibit growth at a CAGR of 4.4% during the forecast period. The increasing demand for chicken meat and eggs, driven by population growth, changing dietary preferences, and urbanization, is propelling the growth of the chicken segment. Poultry producers are prioritizing disease prevention and implementing vaccination programs to safeguard their chicken flocks from Newcastle disease outbreaks. Additionally, favorable government initiatives promoting poultry health, biosecurity measures, and vaccination campaigns specifically targeting chickens contribute to the growth of this segment.
To Understand More About this Research: Request A Free Sample
North America is the largest Newcastle disease vaccine market, accounting for a significant share in the global market. In 2022, the region contributed more than $113.66 million to the market revenue. The dominance of North America can be attributed to the well-established poultry industry, strict biosecurity regulations, and a high focus on disease prevention and control measures.
Looking ahead, North America is projected to continue holding a prominent market share during the forecast period. The region is expected to witness steady growth, with a projected CAGR of 4.3%. Factors such as the increasing demand for poultry products, advancements in vaccine technologies, and the implementation of robust vaccination programs by poultry producers will drive market growth in North America.
In the recent years, the United States experienced a series of outbreaks in its commercial poultry farms, particularly in California, between 2018 and 2019. These outbreaks in the regional Newcastle disease vaccine market led to substantial losses in the poultry industry, including high mortality rates among infected birds and trade restrictions imposed on affected areas. As a result, there was an increased demand for Newcastle disease vaccines to control and prevent the further spread of the virus. In fact, one of our study suggests that the demand for this vaccine has increased by 30% since the outbreak.
In Canada, isolated cases of Newcastle disease have also been reported, leading to temporary farm closures, depopulation efforts, and increased surveillance measures. These outbreaks have caused financial losses for poultry producers and heightened the importance of vaccination programs to mitigate the impact of the disease.
The economic impact of these outbreaks on the North America Newcastle disease vaccine market has underscored the significance of vaccine in the region. Poultry producers have recognized the need for proactive measures to prevent and control the disease, leading to an increased demand for vaccines. The outbreaks have served as a reminder of the critical role of vaccination in protecting poultry populations and maintaining the economic viability of the poultry industry in North America.
By Type
By End Users
By Region
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.
SPEAK TO AN ANALYST
.png)
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
| Report ID: AA0723514 | Delivery: 2 to 4 Hours 
.svg)
